DPT Laboratories’ Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey is now approved to manufacture commercial supplies of Collagenase SANTYL® Ointment. The approval of this facility will double SANTYL® Ointment’s manufacturing capacity, ensuring its supply to the healthcare community.
News
|
Wed, 12/08/2010
|
||
Fri, 10/01/2010
Catherine T. Milne’s recent study evaluated the comparative efficacy of Collagenase SANTYL® Ointment versus a hydrogel dressing in two groups. The study revealed that the Collagenase-treated group achieved statistical significance in complete debridement compared to the hydrogel-treated group. |
||
Tue, 08/10/2010
Healthpoint has initiated a clinical trial to assess the effectiveness of Collagenase SANTYL® Ointment in the wound area of diabetic foot ulcers. This study will help inform the clinical community as to whether an enzymatic debriding agent can positively impact wound closure to avoid amputation in diabetics. |
||
|
Mon, 02/08/2010
In February 2010, Healthpoint announced that 30-gram tubes of Collagenase SANTYL® Ointment would once again be available to pharmacies nationwide. Healthcare providers can prescribe either 15-gram or 30-gram tubes of SANTYL® Ointment for their patients. |